T2D & HIV
HIV and Type 2 Diabetes Clinical Trial: A Diabetic Retinopathy Study
Harold Hamm Diabetes Center is looking for volunteers to participate in a research study evaluating the safety of an approved drug in people diagnosed with HIV, type 2 diabetes, and abdominal lipohypertrophy.
You might be eligible for this study if you:
- Are between 18 and 80 years of age
- Have been diagnosed with HIV and type 2 diabetes
- Have an HbA1c, a test that measures the average amount of sugar in your blood, between 6.0 and 12.0%
- Have excess belly fat (lipohypertrophy)
Qualified participants will receive study-related medication, medical care, and laboratory work at no cost.
To learn more about this study, please call (405) 271-3604.
The University of Oklahoma is an equal opportunity institution.